Professionals 638 results
Capabilities 88 results
Practice Area
Commercial Litigation & Disputes
Industry
Energy Industry Litigation & Investigations
Practice Area
Experience 82 results
Experience
|September 23, 2025
Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals
Experience
|September 8, 2025
Experience
|July 30, 2025
Insights & News 4,304 results
Recognitions
|October 31, 2025
|1 Min Read
Winston & Strawn Ranked in 2025 Chambers Brazil: Transactional Guide
Recognitions
|October 30, 2025
|Less Than 1 Min Read
Winston & Strawn Recognized in 2026 Benchmark Litigation
False Claims Act Playbook
|October 30, 2025
|5 Min Read
On October 15, 2025, the United States District Court for the District of Nebraska (the Court) dismissed Pharos Capital Group and its related investment funds (Pharos Capital) from a qui tam or whistleblower suit brought under the antiretaliation provision of the False Claims Act (31 U.S.C. § 3730(h)) (the FCA), against Pharos Capital and Charter Health Care Group (Charter), a portfolio company of Pharos Capital.
Other Results 103 results
Law Glossary
What Is Advertising Litigation?
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?


